ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
1-Year Est. Return 36.49%
This Quarter Est. Return
1 Year Est. Return
-36.49%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$37.1M
AUM Growth
-$21.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
15
New
Increased
Reduced
Closed

Top Buys

1
+$1.01M
2
+$905K
3
+$247K
4
ARVN icon
Arvinas
ARVN
+$225K

Top Sells

1
+$4.04M
2
+$2.53M
3
+$2.01M
4
KYMR icon
Kymera Therapeutics
KYMR
+$1.23M
5
RGNX icon
Regenxbio
RGNX
+$536K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BPMC
1
DELISTED
Blueprint Medicines
BPMC
$7.43M 13.32%
83,926
-45,674
ARWR icon
2
Arrowhead Research
ARWR
$5.86B
$7.01M 12.57%
550,130
-157,459
PTGX icon
3
Protagonist Therapeutics
PTGX
$4.89B
$3.95M 7.08%
81,692
+5,100
KYMR icon
4
Kymera Therapeutics
KYMR
$4.42B
$3.79M 6.8%
138,521
-45,000
DTIL icon
5
Precision BioSciences
DTIL
$96.2M
$3.46M 6.21%
726,149
+189,773
ARVN icon
6
Arvinas
ARVN
$744M
$2.53M 4.54%
360,766
+32,000
RGNX icon
7
Regenxbio
RGNX
$645M
$1.94M 3.48%
271,302
-75,000
ACET icon
8
Adicet Bio
ACET
$115M
$1.85M 3.32%
2,456,194
-75,000
BCYC
9
Bicycle Therapeutics
BCYC
$559M
$1.46M 2.61%
171,695
-50,216
IMTX icon
10
Immatics
IMTX
$1.24B
$1.38M 2.47%
304,902
-69,000
RPTX icon
11
Repare Therapeutics
RPTX
$79M
$1.28M 2.29%
1,293,715
ZYME icon
12
Zymeworks
ZYME
$1.45B
$1.01M 1.8%
+84,482
AMGN icon
13
Amgen
AMGN
$161B
– –
0
SLN
14
Silence Therapeutics
SLN
$338M
– –
-367,214
STRO icon
15
Sutro Biopharma
STRO
$94.9M
– –
-498